Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ocular Therapeutix Inc. (OCUL)

2.46   -0.19 (-7.17%) 05-23 16:00
Open: 2.55 Pre. Close: 2.61
High: 2.86 Low: 2.54
Volume: 886,507 Market Cap: 105M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.627 - 2.642 2.642 - 2.654
Low: 2.397 - 2.417 2.417 - 2.433
Close: 2.431 - 2.46 2.46 - 2.484

Technical analysis

as of: 2019-05-23 4:27:19 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 4.04     One year: 4.85
Support: Support1: 2.35    Support2: 1.96
Resistance: Resistance1: 3.46    Resistance2: 4.15
Pivot: 3.42
Moving Average: MA(5): 2.91     MA(20): 3.52
MA(100): 3.91     MA(250): 5.26
MACD: MACD(12,26): -0.30     Signal(9): -0.18
Stochastic oscillator: %K(14,3): 13.37     %D(3): 13.44
RSI: RSI(14): 21.05
52-week: High: 8.28  Low: 2.35  Change(%): -63.7
Average Vol(K): 3-Month: 58523  10-Days: 97376

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OCUL has closed below the lower band by 3.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 106.9% wider than normal. The large width of the bands suggest high volatility as compared to OCUL's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Wed, 22 May 2019 00:08:55 Z
Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint

Tue, 21 May 2019 20:26:47 Z
Health Care Sector Update for 05/21/2019: QTNT,ARRY,AMRX,OCUL

Tue, 21 May 2019 18:07:10 Z
Health Care Sector Update for 05/21/2019: ARRY,AMRX,OCUL

Fri, 10 May 2019 15:06:42 Z
Ocular Therapeutix (OCUL) Reports Q1 Loss, Tops Revenue Estimates

Fri, 03 May 2019 17:10:41 Z
Analysts Estimate Ocular Therapeutix (OCUL) to Report a Decline in Earnings: What to Look Out for

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 42.84
Shares Float (M) 41.49
% Held by Insiders
% Held by Institutions 68.20
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.570
EPS Est. Current Year -2.290
EPS Est. Next Year -2.110
EPS Est. Next Quarter -0.530
Forward EPS -1.381
Book Value (p.s.) 5.900
PEG Ratio
Profit Margin
Operating Margin -3049.53
Return on Assets (ttm) -73.9
Return on Equity (ttm) -179.8
Qtrly Rev. Growth 44.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -56.14
Levered Free Cash Flow (M) -34.88

Stock Valuations

P/E -1.57
P/E Growth Ratio -0.07
P/BV 0.42
P/S 2107728128.00
P/CF -1.88

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.